In response to: “Reply to research letter”

Lignende værker

• Reply to: “Do IL-17 inhibitors increase risk of respiratory tract infections?”
  af: Wan, Marilyn T., et al.
  Udgivet: (2020)
• Reply to research letter
  af: Rivera-Oyola, Ryan, et al.
  Udgivet: (2020)
• The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
  af: Wan, Marilyn T., et al.
  Udgivet: (2020)
• The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
  af: Syed, Maha N., et al.
  Udgivet: (2020)
• Commentary
  af: Shin, Daniel B., et al.
  Udgivet: (2021)